Cas:885520-73-0 Methyl 3-iodo-4-nitro-1H-indazole-6-carboxylate manufacturer & supplier

Chemical Name:Methyl 3-iodo-4-nitro-1H-indazole-6-carboxylate

CAS.NO:885520-73-0

Synonyms:Methyl 3-iodo-4-nitro-1H-indazole-6-carboxylate;1H-Indazole-6-carboxylic acid, 3-iodo-4-nitro-, methyl ester;3-Iodo-4-nitro-6-(1H)indazole carboxylic acid methyl ester

Molecular Formula:C₉H₆IN₃O₄

Molecular Weight:347.066

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:511.2±45.0 °C at 760 mmHg

Density:2.1±0.1 g/cm3

Index of Refraction:1.748

PSA:100.80000

Exact Mass:346.940277

LogP:2.75

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Methyl 3-iodo-4-nitro-1H-indazole-6-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Iodo-4-nitro-6-(1H)indazole carboxylic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 3-iodo-4-nitro-1H-indazole-6-carboxylate Use and application,Methyl 3-iodo-4-nitro-1H-indazole-6-carboxylate technical grade,usp/ep/jp grade.

Related News: Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list. Methyl 3-iodo-4-nitro-1H-indazole-6-carboxylate manufacturer Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System. Methyl 3-iodo-4-nitro-1H-indazole-6-carboxylate supplier The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills. Methyl 3-iodo-4-nitro-1H-indazole-6-carboxylate vendor The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers. Methyl 3-iodo-4-nitro-1H-indazole-6-carboxylate factory Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.